Health
High expression of VRK1 protein can reduce survival in neuroblastoma patients – News-Medical.Net
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein…
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumour aggressiveness and low survival among neuroblastoma patients.
Aggressive neuroblastoma is one of the most common solid childhood cancers and causes disproportionately high mortality in affected children. Although advances have been made in recent years, the outlook for recovery in children affected by aggressive…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General14 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled
-
Business24 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Business18 hours agoCounter drone company surges past $1 billion valuation with new contract win